Iminosugar idoBR1 isolated from Cucumber Cucumis sativus reduces inflammatory activity
Nash, Robert J. and Bartholomoew, Barbara and Penkova, Yana B. and Rotondo, Dino and Yamasaka, Fernanda and Stafford, Graham P. and Jenkinson, Sarah F. and Fleet, George W.J. (2020) Iminosugar idoBR1 isolated from Cucumber Cucumis sativus reduces inflammatory activity. ACS Omega, 5 (26). pp. 16263-16271. ISSN 2470-1343 (https://doi.org/10.1021/acsomega.0c02092)
Preview |
Text.
Filename: Nash_etal_Omega_2020_Iminosugar_idoBR1_isolated_from_Cucumber_Cucumis_sativus_reduces_inflammatory_activity.pdf
Final Published Version License: Other Download (2MB)| Preview |
Abstract
Cucumbers have been anecdotally claimed to have anti-inflammatory activity for a long time, but the active principle was not identified. idoBR1, (2R,3R,4R,5S)-3,4,5-trihydroxypiperidine-2-carboxylic acid, is an iminosugar amino acid isolated from fruits of certain cucumbers, Cucumis sativus (Cucurbitaceae). It has no chromophore and analytically behaves like an amino acid making detection and identification difficult. It has anti-inflammatory activity reducing lipopolysaccharide (LPS)-induced tumor necrosis factor alpha (TNF-α) in THP-1 cells and ex vivo human blood. It showed selective inhibition of human α-l-iduronidase and sialidases from both bacteria (Tannerella forsythia) and human THP-1 cells. idoBR1 and cucumber extract reduced the binding of hyaluronic acid (HA) to CD44 in LPS-stimulated THP-1 cells and may function as an anti-inflammatory agent by inhibiting induced sialidase involved in the production of functionally active HA adhesive CD44. Similar to the related iminosugars, idoBR1 is excreted unchanged in urine following consumption. Its importance in the diet should be further evaluated.
ORCID iDs
Nash, Robert J., Bartholomoew, Barbara, Penkova, Yana B., Rotondo, Dino ORCID: https://orcid.org/0000-0002-9008-4329, Yamasaka, Fernanda, Stafford, Graham P., Jenkinson, Sarah F. and Fleet, George W.J.;-
-
Item type: Article ID code: 73183 Dates: DateEvent7 July 2020Published23 June 2020Published Online11 June 2020AcceptedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 14 Jul 2020 10:01 Last modified: 15 Dec 2024 01:31 URI: https://strathprints.strath.ac.uk/id/eprint/73183